|
CAMBRIDGE, England, July 22, 2015 /PRNewswire/ --
Darktrace, the leader in Enterprise Immune System technology, announced today that it has raised $22.5 million in Series B funding from Summit Partners, a global growth equity investor that has raised more than $16 billion in capital... |
